Voltaic Strategic Resources (ASX:VSR) - CEO, Michael Walshe
CEO, Michael Walshe
Source: The Market Herald
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Voltaic Strategic Resources (VSR) kicks off a new drilling campaign at its Ti Tree lithium project in the Gascoyne region of Western Australia
  • The company plans 3500 metres of RC drilling at its Morpheus, Akira and Lewis prospects which have high-priority surface geochemical anomalies
  • The Morpheus and Akira targets are located in the ‘Goldilocks’ zone
  • The company is planning down-dip deeper drilling at the Anrada prospect to examine untested LCT potential targets
  • Shares are up 2.44 per cent, trading at 4.2 cents at 1:41 pm AEST

Voltaic Strategic Resources (VSR) has kicked off a phase three drilling campaign at its Ti Tree lithium project in the Gascoyne region of Western Australia.

The company has planned 3500 metres of reverse circulation (RC) drilling at its Morpheus, Akira and Lewis prospects with high-priority surface geochemical anomalies.

The Morpheus and Akira targets are located in the ‘Goldilocks’ zone, where “significant” intersections have been identified by Delta Lithium at the Yinnietharra lithium project neighbouring Ti Tree.

“The RC drill rig being employed has the capacity to drill deeper than previous campaigns allowing us to thoroughly examine the extents of the pegmatite swarms at each prospect and potentially vector to mineralisation at depth and undercover,” Voltaic CEO Michael Walshe said.

The company has also planned down-dip deeper drilling at the Anrada prospect to examine untested lithium-caesium-tantalum (LCT) potential targets.

VSR was up 2.44 per cent, trading at 4.2 cents at 1:41 pm AEST.

vsr by the numbers
More From The Market Online
The Market Online Video

Market Close: ASX 200 rallies as risk appetite returns, but business confidence weakens

The Australian sharemarket finished firmly higher today with the S&P/ASX 200 adding 106.50 points, or 1.18%, to close at 9,136.20.

EVE Health Group signs Australian compounding agreement for rapidly rising Men’s Health issue

EVE Health Group has signed an agreement with Optimal Pharmacy Plus Stafford aimed at the Australian…

Nanoveu’s EMASS signs DigiKey as Global Distributor for ECS-DoT-22

Nanoveu's wholly-owned subsidiary EMASS has signed DigiKey as its global distributor for ECS-DoT-22 system.
The Market Online Video

Wealth Within: Wall Street Tech Sinks While ASX Tech Soars

Wall Street’s technology stocks have been hammered, with the Nasdaq plunging 5.5 per cent in a single session and Nvidia falling more tha…